Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
HUB Group
HUBG
$2.43B
| $23.2M | 0.04% |
1,272,916
+52,788
| +4% | +$1.04M |
|
|
AERI
502
DELISTED
Aerie Pharmaceuticals
AERI
| $23.2M | 0.04% |
1,305,553
+1,021,302
| +359% | +$18.5M |
|
503
CBRE Group
CBRE
$43.8B
| $23.1M | 0.04% |
721,431
-633,196
| -47% | -$22.5M |
|
504
KBR
KBR
$4.75B
| $23M | 0.04% |
1,381,913
-554,011
| -29% | -$9.76M |
|
505
Jacobs Solutions
J
$17.8B
| $22.9M | 0.04% |
+739,447
| New | +$24.7M |
|
506
Piper Sandler
PIPR
$5.28B
| $22.8M | 0.04% |
2,518,224
+1,903,432
| +310% | +$19.5M |
|
|
ELGX
507
DELISTED
Endologix Inc
ELGX
| $22.8M | 0.04% |
185,642
+71,114
| +62% | +$9.65M |
|
|
INVX
508
Innovex International
INVX
$2.01B
| $22.7M | 0.04% |
389,428
+284,819
| +272% | +$18.1M |
|
|
CBPX
509
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $22.6M | 0.04% |
1,101,444
+719,279
| +188% | +$15.1M |
|
|
PPLI
510
People Inc
PPLI
$2.88B
| $22.5M | 0.04% |
+1,928,043
| New | +$25.6M |
|
|
NTI
511
DELISTED
NORTHERN TIER ENERGY LP CLASS A
NTI
| $22.4M | 0.04% |
+983,960
| New | +$24.7M |
|
|
TMH
512
DELISTED
Team Health Holdings Inc
TMH
| $22.3M | 0.04% |
413,629
+138,116
| +50% | +$8.63M |
|
513
Jabil
JBL
$32.1B
| $22.3M | 0.04% |
998,941
+219,209
| +28% | +$4.36M |
|
|
GRFS
514
Grifois
GRFS
$5.44B
| $22.3M | 0.04% |
1,467,224
-306,452
| -17% | -$4.86M |
|
|
MW
515
DELISTED
THE MENS WAREHOUSE INC
MW
| $22.3M | 0.04% |
523,834
+482,210
| +1,158% | +$26.7M |
|
516
F5
FFIV
$21.6B
| $22.2M | 0.04% |
192,079
-171,340
| -47% | -$21M |
|
|
ACOR
517
DELISTED
Acorda Therapeutics
ACOR
| $22.2M | 0.04% |
6,990
+3,545
| +103% | +$13.7M |
|
|
CERN
518
DELISTED
Cerner Corp
CERN
| $22.2M | 0.04% |
370,710
+240,189
| +184% | +$15.7M |
|
|
EXPR
519
DELISTED
Express, Inc.
EXPR
| $22M | 0.04% |
61,656
+23,031
| +60% | +$8.66M |
|
520
Acadia Realty Trust
AKR
$2.91B
| $21.9M | 0.04% |
728,089
+16,869
| +2% | +$519K |
|
521
Bank of America
BAC
$437B
| $21.8M | 0.04% |
1,398,394
-7,792,497
| -85% | -$131M |
|
|
DFT
522
DELISTED
DuPont Fabros Technology Inc.
DFT
| $21.7M | 0.04% |
840,012
+722,064
| +612% | +$20.5M |
|
|
CHS
523
DELISTED
Chicos FAS, Inc.
CHS
| $21.7M | 0.04% |
+1,379,755
| New | +$21.4M |
|
|
524
Bank of America Series L
BAC.PRL
$3.97B
| $21.7M | 0.04% |
20,144
+16,324
| +427% | +$18.1M |
|
|
PKY
525
DELISTED
Parkway, Inc.
PKY
| $21.6M | 0.04% |
1,389,591
+1,115,847
| +408% | +$18.8M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.